 | • レポートコード：QYR9N7048 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当資料は、クッシング病治療のグローバル市場について調査・分析したレポートで、種類別（ケトコナゾール、ミトタン、アミノグルテチミド、メチラポン、ミフェプリストン、その他）、用途別（病院薬局、小売薬局、ドラッグストア、診療所、Eコマース/オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・クッシング病治療の世界市場規模 ・主要企業別市場シェア ・クッシング病治療の世界市場規模：種類別（ケトコナゾール、ミトタン、アミノグルテチミド、メチラポン、ミフェプリストン、その他） ・クッシング病治療の世界市場規模：用途別（病院薬局、小売薬局、ドラッグストア、診療所、Eコマース/オンライン薬局） ・クッシング病治療のアメリカ市場規模（種類別、用途別） ・クッシング病治療のヨーロッパ市場規模（種類別、用途別） ・クッシング病治療の中国市場規模（種類別、用途別） ・クッシング病治療の日本市場規模（種類別、用途別） ・クッシング病治療の東南アジア市場規模（種類別、用途別） ・クッシング病治療のインド市場規模（種類別、用途別） ・クッシング病治療の中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・クッシング病治療の世界市場予測（2019年-2025年） ・クッシング病治療の地域別市場予測（2019年-2025年） ... |
Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal with injury or infection. Increasing levels of cortisol increases the blood sugar and can even cause diabetes mellitus. However the disease is also caused due to excess production of hypothalamus corticotropin releasing hormone (CRH) which stimulates the synthesis of cortisol by the adrenal glands.Cushing’s disease treatment market revenue is growing with a stable growth rate, this is attributed to increasing number of pipeline drugs. Also increasing interest of pharmaceutical companies to develop Cushing disease drugs is a major factor contributing to the revenue growth of Cushing disease treatment market over the forecast period. Current and emerging players’ focuses on physician education and awareness regarding availability of different drugs for curing Cushing disease, thus increasing the referral speeds, time to diagnosis and volume of diagnosed Cushing disease individuals. Growing healthcare expenditure and increasing awareness regarding Cushing syndrome aids in the revenue growth of Cushing’s disease treatment market. Increasing number of new product launches also drives the market for Cushing’s disease Treatment devices. However availability of alternative therapies for curing Cushing syndrome is expected to hamper the growth of the Cushing’s disease treatment market over the forecast period.
In 2018, the global Cushing’s Disease Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Cushing’s Disease Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cushing’s Disease Treatment development in United States, Europe and China.
The key players covered in this study
CORCEPT THERAPEUTICS
HRA Pharma
Strongbridge Biopharma
Novartis
…
Market segment by Type, the product can be split into
Ketoconazole
Mitotane
Aminoglutethimide
Metyrapone
Mifepristone
Etomidate
Pasireotide
Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Clinics
E-Commerce/Online Pharmacies
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Cushing’s Disease Treatment status, future forecast, growth opportunity, key market and key players.
To present the Cushing’s Disease Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Cushing’s Disease Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Cushing’s Disease Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Ketoconazole
1.4.3 Mitotane
1.4.4 Aminoglutethimide
1.4.5 Metyrapone
1.4.6 Mifepristone
1.4.7 Etomidate
1.4.8 Pasireotide
1.5 Market by Application
1.5.1 Global Cushing’s Disease Treatment Market Share by Application (2014-2025)
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Drug Stores
1.5.5 Clinics
1.5.6 E-Commerce/Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Cushing’s Disease Treatment Market Size
2.2 Cushing’s Disease Treatment Growth Trends by Regions
2.2.1 Cushing’s Disease Treatment Market Size by Regions (2014-2025)
2.2.2 Cushing’s Disease Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Cushing’s Disease Treatment Market Size by Manufacturers
3.1.1 Global Cushing’s Disease Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Cushing’s Disease Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Cushing’s Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Cushing’s Disease Treatment Key Players Head office and Area Served
3.3 Key Players Cushing’s Disease Treatment Product/Solution/Service
3.4 Date of Enter into Cushing’s Disease Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Cushing’s Disease Treatment Market Size by Type (2014-2019)
4.2 Global Cushing’s Disease Treatment Market Size by Application (2014-2019)
5 United States
5.1 United States Cushing’s Disease Treatment Market Size (2014-2019)
5.2 Cushing’s Disease Treatment Key Players in United States
5.3 United States Cushing’s Disease Treatment Market Size by Type
5.4 United States Cushing’s Disease Treatment Market Size by Application
6 Europe
6.1 Europe Cushing’s Disease Treatment Market Size (2014-2019)
6.2 Cushing’s Disease Treatment Key Players in Europe
6.3 Europe Cushing’s Disease Treatment Market Size by Type
6.4 Europe Cushing’s Disease Treatment Market Size by Application
7 China
7.1 China Cushing’s Disease Treatment Market Size (2014-2019)
7.2 Cushing’s Disease Treatment Key Players in China
7.3 China Cushing’s Disease Treatment Market Size by Type
7.4 China Cushing’s Disease Treatment Market Size by Application
8 Japan
8.1 Japan Cushing’s Disease Treatment Market Size (2014-2019)
8.2 Cushing’s Disease Treatment Key Players in Japan
8.3 Japan Cushing’s Disease Treatment Market Size by Type
8.4 Japan Cushing’s Disease Treatment Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Cushing’s Disease Treatment Market Size (2014-2019)
9.2 Cushing’s Disease Treatment Key Players in Southeast Asia
9.3 Southeast Asia Cushing’s Disease Treatment Market Size by Type
9.4 Southeast Asia Cushing’s Disease Treatment Market Size by Application
10 India
10.1 India Cushing’s Disease Treatment Market Size (2014-2019)
10.2 Cushing’s Disease Treatment Key Players in India
10.3 India Cushing’s Disease Treatment Market Size by Type
10.4 India Cushing’s Disease Treatment Market Size by Application
11 Central & South America
11.1 Central & South America Cushing’s Disease Treatment Market Size (2014-2019)
11.2 Cushing’s Disease Treatment Key Players in Central & South America
11.3 Central & South America Cushing’s Disease Treatment Market Size by Type
11.4 Central & South America Cushing’s Disease Treatment Market Size by Application
12 International Players Profiles
12.1 CORCEPT THERAPEUTICS
12.1.1 CORCEPT THERAPEUTICS Company Details
12.1.2 Company Description and Business Overview
12.1.3 Cushing’s Disease Treatment Introduction
12.1.4 CORCEPT THERAPEUTICS Revenue in Cushing’s Disease Treatment Business (2014-2019)
12.1.5 CORCEPT THERAPEUTICS Recent Development
12.2 HRA Pharma
12.2.1 HRA Pharma Company Details
12.2.2 Company Description and Business Overview
12.2.3 Cushing’s Disease Treatment Introduction
12.2.4 HRA Pharma Revenue in Cushing’s Disease Treatment Business (2014-2019)
12.2.5 HRA Pharma Recent Development
12.3 Strongbridge Biopharma
12.3.1 Strongbridge Biopharma Company Details
12.3.2 Company Description and Business Overview
12.3.3 Cushing’s Disease Treatment Introduction
12.3.4 Strongbridge Biopharma Revenue in Cushing’s Disease Treatment Business (2014-2019)
12.3.5 Strongbridge Biopharma Recent Development
12.4 Novartis
12.4.1 Novartis Company Details
12.4.2 Company Description and Business Overview
12.4.3 Cushing’s Disease Treatment Introduction
12.4.4 Novartis Revenue in Cushing’s Disease Treatment Business (2014-2019)
12.4.5 Novartis Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Cushing’s Disease Treatment Key Market Segments
Table Key Players Cushing’s Disease Treatment Covered
Table Global Cushing’s Disease Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Cushing’s Disease Treatment Market Size Market Share by Type 2014-2025
Figure Ketoconazole Figures
Table Key Players of Ketoconazole
Figure Mitotane Figures
Table Key Players of Mitotane
Figure Aminoglutethimide Figures
Table Key Players of Aminoglutethimide
Figure Metyrapone Figures
Table Key Players of Metyrapone
Figure Mifepristone Figures
Table Key Players of Mifepristone
Figure Etomidate Figures
Table Key Players of Etomidate
Figure Pasireotide Figures
Table Key Players of Pasireotide
Table Global Cushing’s Disease Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Pharmacies Case Studies
Figure Retail Pharmacies Case Studies
Figure Drug Stores Case Studies
Figure Clinics Case Studies
Figure E-Commerce/Online Pharmacies Case Studies
Figure Cushing’s Disease Treatment Report Years Considered
Table Global Cushing’s Disease Treatment Market Size 2014-2025 (Million US$)
Figure Global Cushing’s Disease Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Cushing’s Disease Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Cushing’s Disease Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Cushing’s Disease Treatment Market Share by Regions 2014-2019
Figure Global Cushing’s Disease Treatment Market Share by Regions 2014-2019
Figure Global Cushing’s Disease Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Cushing’s Disease Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Cushing’s Disease Treatment Market Share by Manufacturers (2014-2019)
Figure Global Cushing’s Disease Treatment Market Share by Manufacturers in 2018
Table Global Cushing’s Disease Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Cushing’s Disease Treatment Product/Solution/Service
Table Date of Enter into Cushing’s Disease Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Cushing’s Disease Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Cushing’s Disease Treatment Market Size Share by Type (2014-2019)
Figure Global Cushing’s Disease Treatment Market Size Market Share by Type (2014-2019)
Table Global Cushing’s Disease Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Cushing’s Disease Treatment Market Size Share by Application (2014-2019)
Figure Global Cushing’s Disease Treatment Market Size Market Share by Application (2014-2019)
Figure Global Cushing’s Disease Treatment Revenue Market Share by Application in 2018
Figure United States Cushing’s Disease Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Cushing’s Disease Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Cushing’s Disease Treatment Market Share (2018-2019)
Table United States Cushing’s Disease Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Cushing’s Disease Treatment Market Share by Type (2014-2019)
Table United States Cushing’s Disease Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Cushing’s Disease Treatment Market Share by Application (2014-2019)
Figure Europe Cushing’s Disease Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Cushing’s Disease Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Cushing’s Disease Treatment Market Share (2018-2019)
Table Europe Cushing’s Disease Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Cushing’s Disease Treatment Market Share by Type (2014-2019)
Table Europe Cushing’s Disease Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Cushing’s Disease Treatment Market Share by Application (2014-2019)
Figure China Cushing’s Disease Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Cushing’s Disease Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Cushing’s Disease Treatment Market Share (2018-2019)
Table China Cushing’s Disease Treatment Market Size by Type (2014-20189) (Million US$)
Table China Cushing’s Disease Treatment Market Share by Type (2014-2019)
Table China Cushing’s Disease Treatment Market Size by Application (2014-2019) (Million US$)
Table China Cushing’s Disease Treatment Market Share by Application (2014-2019)
Figure Japan Cushing’s Disease Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Cushing’s Disease Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Cushing’s Disease Treatment Market Share (2018-2019)
Table Japan Cushing’s Disease Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Cushing’s Disease Treatment Market Share by Type (2014-2019)
Table Japan Cushing’s Disease Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Cushing’s Disease Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Cushing’s Disease Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Cushing’s Disease Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Cushing’s Disease Treatment Market Share (2018-2019)
Table Southeast Asia Cushing’s Disease Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Cushing’s Disease Treatment Market Share by Type (2014-2019)
Table Southeast Asia Cushing’s Disease Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Cushing’s Disease Treatment Market Share by Application (2014-2019)
Figure India Cushing’s Disease Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Cushing’s Disease Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Cushing’s Disease Treatment Market Share (2018-2019)
Table India Cushing’s Disease Treatment Market Size by Type (2014-2019) (Million US$)
Table India Cushing’s Disease Treatment Market Share by Type (2014-2019)
Table India Cushing’s Disease Treatment Market Size by Application (2014-2019) (Million US$)
Table India Cushing’s Disease Treatment Market Share by Application (2014-2019)
Figure Central & South America Cushing’s Disease Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Cushing’s Disease Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Cushing’s Disease Treatment Market Share (2018-2019)
Table Central & South America Cushing’s Disease Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Cushing’s Disease Treatment Market Share by Type (2014-2019)
Table Central & South America Cushing’s Disease Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Cushing’s Disease Treatment Market Share by Application (2014-2019)
Table CORCEPT THERAPEUTICS Company Details
Table CORCEPT THERAPEUTICS Revenue in Cushing’s Disease Treatment Business (2014-2019) (Million US$)
Figure CORCEPT THERAPEUTICS Revenue Growth Rate in Cushing’s Disease Treatment Business (2014-2019)
Table CORCEPT THERAPEUTICS Recent Development
Table HRA Pharma Company Details
Table HRA Pharma Revenue in Cushing’s Disease Treatment Business (2014-2019)(Million US$)
Figure HRA Pharma Revenue Growth Rate in Cushing’s Disease Treatment Business (2014-2019)
Table HRA Pharma Recent Development
Table Strongbridge Biopharma Company Details
Table Strongbridge Biopharma Revenue in Cushing’s Disease Treatment Business (2014-2019)(Million US$)
Figure Strongbridge Biopharma Revenue Growth Rate in Cushing’s Disease Treatment Business (2014-2019)
Table Strongbridge Biopharma Recent Development
Table Novartis Company Details
Table Novartis Revenue in Cushing’s Disease Treatment Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Cushing’s Disease Treatment Business (2014-2019)
Table Novartis Recent Development
Table Global Cushing’s Disease Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Cushing’s Disease Treatment Market Size Share by Regions (2019-2025)
Figure Global Cushing’s Disease Treatment Market Size Share by Regions in 2025
Figure United States Cushing’s Disease Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Cushing’s Disease Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Cushing’s Disease Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Cushing’s Disease Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Cushing’s Disease Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Cushing’s Disease Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Cushing’s Disease Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Cushing’s Disease Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Cushing’s Disease Treatment Market Size by Product (2019-2025)
Figure Global Cushing’s Disease Treatment Market Size by Product in 2025
Table Global Cushing’s Disease Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Cushing’s Disease Treatment Market Size by Application (2019-2025)
Figure Global Cushing’s Disease Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界のクッシング症候群の治療市場：市場規模・現状・予測 Cushing's syndrome involves symptoms such as high blood pressure, abdominal obesity, round red face, a fatty lump between the shoulders, weak muscles and bones, acne, fragile skin and others. Most Cushing's syndrome cases are caused by pituitary adenoma, and multiple endocrine neoplasia.In terms of …- 世界のまれな神経疾患治療市場：市場規模・現状・予測 In 2018, the global Rare Neurological Disease Treatment market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025. This report focuses on the global Rare Neurological Disease Treatment status, future forecast, growth opportunity, key mark…
- 世界のまれな病気の治療市場：市場規模・現状・予測 A rare disease is any disease that affects a small percentage of the population.Most rare diseases are genetic and thus are present throughout the person's entire life, even if symptoms do not immediately appear. In 2018, the global Rare Disease Treatment market size was xx million US$ and it is exp…
- 世界のまれな内分泌疾患の治療市場：市場規模・現状・予測 The endocrine system is a chemical messenger system consisting of hormones, the group of glands of an organism that carry those hormones directly into the circulatory system to be carried towards distant target organs and the feedback loops of homeostasis that the hormones drive.The rare endocrine d…
- 世界のまれな炎症性疾患の治療市場：市場規模・現状・予測 In 2018, the global Rare Inflammatory Disease Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Rare Inflammatory Disease Treatment status, future forecast, growth opportunity…